CTSB and skin basal cell carcinoma: Cathepsin B demonstrated a promoting effect on BCC (OR = 1.092, 95% CI: 1.026–1.163, P < .05) and a tendency for non-melanoma (OR = 1.182, 95% CI: 0.995–1.404, P = .06).